The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/11914
StudyName: Eligibility Multiple Sclerosis Betaferon/Betaseron NCT00099502
Date of export from the portal: 02.07.2020
Date of Upload / last change: 21.08.2015
License: Creative Commons BY 4.0

----

Description: 
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

https://clinicaltrials.gov/ct2/show/NCT00099502
        The purpose of this study is to determine

        -  whether treatment with Betaferon / Betaseron (interferon beta-1b)  500 micrograms safe,
        tolerable and more efficacious than treatment with interferon beta-1b  250 micrograms

        -  whether  treatment with Betaferon / Betaseron (interferon beta-1b) tolerable and more
        efficacious than treatment with Copaxone  (Glatiramer Acetate) 20 mg
      
